Atomoxetine and DAW2022 on OSA Severity
Condition(s):Obstructive Sleep ApneaLast Updated:May 2, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Obstructive Sleep ApneaLast Updated:May 2, 2022Not yet recruiting
Condition(s):Obesity, MorbidLast Updated:March 22, 2022Recruiting
Condition(s):Continuous Methamphetamine Dependence; Methamphetamine Dependence in RemissionLast Updated:May 12, 2016Completed
Condition(s):Alcohol Use DisorderLast Updated:May 6, 2022Recruiting
Condition(s):Atomoxetine Hydrochloride; PlacebosLast Updated:August 14, 2017Completed
Condition(s):Memory Disorders; Multiple SclerosisLast Updated:March 13, 2020Completed
Condition(s):Mild Cognitive ImpairmentLast Updated:July 23, 2019Completed
Condition(s):Neurogenic Orthostatic HypotensionLast Updated:April 5, 2019Completed
Condition(s):Post Traumatic Stress Disorder; Attention Deficit Hyperactivity DisorderLast Updated:April 3, 2019Completed
Condition(s):Tourette SyndromeLast Updated:January 29, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.